Bangladesh inks COVID-19 vaccine production agreement with China

An agreement has been signed between the Sinopharm of China, Ministry of Health and Family Welfare, People’s Republic of Bangladesh and Incepta Vaccine, at the Bangladesh College of Physicians and Surgeons (BCPS), Mohakhali Dhaka in order to produce the Sinopharm COVID-19 vaccine in Bangladesh. According to Incepta Vaccine, a new direction has been unveiled with this agreement in the production of COVID-19 vaccine in Bangladesh. It is expected that through this agreement, Bangladesh-based company, Incepta Vaccine would produce the Sinopharm COVID-19 vaccine very soon in the country. On the other hand, the Asian Development Bank (ADB) is helping the Bangladesh government strengthen its vaccine delivery system through ongoing technical assistance projects worth $1.7 million. In addition, ADB has supported Bangladesh’s COVID-19 response through a $250 million loan in June 2021.